Aquestive Pharma (AQST): Narxning prognoz qilingan daromadga nisbati

Aquestive Therapeutics (AQST) - korporativ logo

GURU.Markets platformasida forward P/S baholash tarixini kuzatib borar ekanmiz, 10.20 ko'rsatkichi Aquestive Therapeutics (AQST) uchun joriy daraja bo'lib xizmat qilishini qayd etamiz. Ushbu tendentsiya kompaniyaning barqaror daromad keltiruvchi dori-plenkalari uchun eksklyuziv patentlarga egaligini hamda brendning innovatsiya yetakchisi sifatidagi nufuzining ortayotganini aks ettiradi. Ishlab chiqarish jarayonida qo'l mehnatini butunlay bartaraf etuvchi AI boshqaruvi ostidagi robotlashtirilgan zavodlar biznes samaradorligini yanada mustahkamlaydi.

AQST (aquestive.com) Forvard P/S multiplikatori tarixi 04.07.2022dan 15.11.2026gacha

Aquestive Therapeutics kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya narxi Aquestive Therapeutics Inc|AQST - Tahlilchilar konsensus prognozi
- birja kapitallashuvi ma'lumotlari:
Bozor qiymati Aquestive Therapeutics, Inc.|AQST - To‘liq yutib yuborishda kompaniya qiymati
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya uchun buxgalteriya qiymati Aquestive Therapeutics|AQST - Balans kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati aquestive.com|AQST - Kompaniya aktivlari
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Qarzning xususiy kapitalga nisbati Aquestive Therapeutics|AQST - Uzoq muddatli qarzdorlikning kapitalga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Aquestive Therapeutics|AQST - Kompaniyaning yig'indi qarzdorligi|Balans kapitallashuviga qarzlar Aquestive Pharma|AQST - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli majburiyatlari Aquestive Therapeutics|Tezkor likvidlik koeffitsiyenti aquestive.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
AQST - Kompaniyaning sof daromadi|Kelajakdagi foyda Aquestive Therapeutics|AQST - Kompaniya qiymatining sof foydaga nisbati|Prognoz qilingan narxning foydaga nisbati Aquestive Pharma|AQST - Kompaniya qiymatining foyda o‘sish sur’atiga nisbati|EV/EBITDA multiplikatori Aquestive Therapeutics Inc|AQST - Foizlar, soliqlar va amortizatsiya chegirilmasdan oldingi daromad|Bir aksiya uchun sof foyda (EPS TTM) Aquestive Therapeutics|AQST - So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foydaning yillik o'sishi aquestive.com|AQST - Joriy yilda bir aksiya uchun foyda ortishi|Keyingi yil uchun foyda o'sishi prognozi Aquestive Therapeutics
- umumiy tushum va sotuv hajmi ma'lumotlari:
AQST - Daromad va sotish hajmi|Kompaniyaning prognoz qilingan daromadi Aquestive Therapeutics, Inc.|AQST - Narxning sotuvga nisbati|Forvard P/S multiplikatori Aquestive Corp|AQST - Sirpanuvchi yil davomida daromad o'sishi
Kompaniyaning umumiy tahlili:Aquestive Corp AQST
aquestive.com original mahsuloti

Aquestive Therapeutics (AQST) yuqori xavfli dori vositalarini yetkazib berish tizimlari segmentida faoliyat yuritadi. Bashorat qilingan P/S tendentsiyasini tahlil qilish orqali investor kutilayotgan daromadga nisbatan bozor kapitalizatsiyasi dinamikasini baholaydi. Ushbu istiqbolli koeffitsient biznes baholanishining tiklanish tezligini va bozorning kelajakdagi pul oqimlariga bo'lgan ishonch darajasini o'lchaydi. Aquestive Therapeutics (AQST) uchun bu tartibga soluvchi o'zgarishlar va zararsiz nuqtaga yetguncha kapital yetishmovchiliklar sharoitida barqarorlikning muhim ko'rsatkichi hisoblanadi.

Raqobatdosh kompaniyalar tahlili

Forvard P/S multiplikatori HLN (Haleon PLC)|Forvard P/S multiplikatori Kenvue Corp KVUE|Verona Pharma PLC - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati jyongbio.com|LGND: Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati AMRX|Narxning prognoz qilingan daromadga nisbati Perrigo Company|Bozor kapitallashuvining kelajakdagi daromadga nisbati Alvotech ALVO|Forvard P/S multiplikatori LQDA|GLPG: Kelajakdagi narxning daromadga nisbati|Forvard P/S multiplikatori ANIP (ANI Pharmaceuticals, Inc.)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati MannKind Corp (MNKD)|AMPH: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx PCRX (Pacira)|ARS Pharmaceuticals (SPRY) - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning prognoz qilingan daromadga nisbati TBPH|SCPH (scpharmaceuticals.com) - Forvard P/S multiplikatori|TECX: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Sotuvga nisbatan forvard narx BHST|Invizyne Technologies - Forvard P/S multiplikatori|oramed.com (ORMP) - Forvard narx/daromad multiplikatori|ENTX (enterabio.com) - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati HYFT|ABVC (ABVC BioPharma, Inc) - Forvard P/S multiplikatori|Forvard P/S multiplikatori cumberlandpharma.com|Narxning prognoz qilingan daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Prognoz narxning daromadga nisbati|Forvard P/S multiplikatori TELO (telomirpharma.com)|RANI - Forvard narx/daromad multiplikatori|SNYR - Narxning prognoz qilingan daromadga nisbati|rallybio.com - Narxning kutilayotgan daromadga nisbati|LEXX: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Pulmatrix Inc|PTHL (Pheton Holdings) - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aptorum Group Limited APM|Narxning prognoz qilingan daromadga nisbati Lyra Therapeutics (LYRA)|Forvard narx/daromad multiplikatori Impact BioMedical Inc IBO|Narxning prognoz qilingan daromadga nisbati tnfpharma.com TNFA|Sotuvga nisbatan forvard narx YCBD|PainReform Ltd - Forvard P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Forvard narx/daromad multiplikatori|lipella.com (LIPO) - Narxning prognoz qilingan daromadga nisbati|OptiNose (OPTN) - Forvard P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - Forvard P/S multiplikatori|PROC: Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Petros Pharmaceuticals, Inc. (PTPI)|Forvard P/S multiplikatori Qilian International Corp (QLI)|ACELYRIN, Inc. - Forvard narx/daromad multiplikatori|Forvard P/S multiplikatori tffpharma.com TFFP